143 related articles for article (PubMed ID: 12477622)
1. Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy.
Shimada K; Baba T; Neugebauer S; Onozaki A; Yamada D; Midorikawa S; Sato W; Watanabe T
J Diabetes Complications; 2002; 16(6):386-90. PubMed ID: 12477622
[TBL] [Abstract][Full Text] [Related]
2. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.
Hovind P; Tarnow L; Oestergaard PB; Parving HH
Kidney Int Suppl; 2000 Apr; 75():S56-61. PubMed ID: 10828763
[TBL] [Abstract][Full Text] [Related]
3. Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition.
Chaturvedi N; Fuller JH; Pokras F; Rottiers R; Papazoglou N; Aiello LP;
Diabet Med; 2001 Apr; 18(4):288-94. PubMed ID: 11437859
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking.
Wasada T; Kawahara R; Katsumori K; Naruse M; Omori Y
Metabolism; 1998 Jan; 47(1):27-30. PubMed ID: 9440473
[TBL] [Abstract][Full Text] [Related]
5. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
[TBL] [Abstract][Full Text] [Related]
7. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria.
Santilli F; Spagnoli A; Mohn A; Tumini S; Verrotti A; Cipollone F; Mezzetti A; Chiarelli F
J Clin Endocrinol Metab; 2001 Aug; 86(8):3871-6. PubMed ID: 11502826
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell-selective adhesion molecule in diabetic nephropathy.
Kacso IM; Kacso G
Eur J Clin Invest; 2012 Nov; 42(11):1227-34. PubMed ID: 22957687
[TBL] [Abstract][Full Text] [Related]
9. Study of Angiopoietin-2 and vascular endothelial growth factor as markers of diabetic nephropathy onset in Egyptians diabetic patients with non-albuminuric state.
Aly MH; Arafat MA; Hussein OA; Elsaid HH; Abdel-Hammed AR
Diabetes Metab Syndr; 2019; 13(2):1623-1627. PubMed ID: 31336531
[TBL] [Abstract][Full Text] [Related]
10. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
Lin SY; Wang YY; Sheu WH
Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636
[TBL] [Abstract][Full Text] [Related]
11. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
[TBL] [Abstract][Full Text] [Related]
12. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
Kacso IM; Bondor CI; Kacso G
Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
Peng XP; Li JD; Li MD; Ye XM; Yan WC
Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
[TBL] [Abstract][Full Text] [Related]
14. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
Shao Y; Lv C; Yuan Q; Wang Q
J Diabetes Res; 2016; 2016():1925424. PubMed ID: 27069929
[TBL] [Abstract][Full Text] [Related]
15. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A
Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
17. Serum and Plasma Levels of Vascular Endothelial Growth Factors in Relation to Quality of Glucose Control, Biomarkers of Inflammation, and Diabetic Nephropathy.
Hanefeld M; Appelt D; Engelmann K; Sandner D; Bornstein SR; Ganz X; Henkel E; Haase R; Birkenfeld AL
Horm Metab Res; 2016 Aug; 48(8):529-34. PubMed ID: 27388431
[TBL] [Abstract][Full Text] [Related]
18. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients.
Tanaka Y; Atsumi Y; Matsuoka K; Onuma T; Tohjima T; Kawamori R
Diabetes Care; 1998 Jan; 21(1):116-20. PubMed ID: 9538981
[TBL] [Abstract][Full Text] [Related]
19. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
[TBL] [Abstract][Full Text] [Related]
20. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
